Cargando…
Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline
Mycobacterium abscessus is the most common rapidly growing non-tuberculous mycobacteria to cause pulmonary disease in patients with impaired lung function such as cystic fibrosis. M. abscessus displays high intrinsic resistance to common antibiotics and inducible resistance to macrolides like clarit...
Autores principales: | Sullivan, Jaryd R., Lupien, Andréanne, Kalthoff, Elias, Hamela, Claire, Taylor, Lorne, Munro, Kim A., Schmeing, T. Martin, Kremer, Laurent, Behr, Marcel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535176/ https://www.ncbi.nlm.nih.gov/pubmed/34637487 http://dx.doi.org/10.1371/journal.ppat.1009965 |
Ejemplares similares
-
Epetraborole Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021) -
Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex
por: Sullivan, Jaryd R., et al.
Publicado: (2022) -
2064. In Vitro Susceptibility of Recent Mycobacterium abscessus Isolates to Epetraborole (EBO) and Comparators by Broth Microdilution
por: Nguyen, Minh-Vu H, et al.
Publicado: (2023) -
Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus
por: Johansen, Matt D., et al.
Publicado: (2021) -
A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus
por: Kim, Taeho, et al.
Publicado: (2021)